Join us as we bring powerful stories to life.
Promethean BioPharma has developed a nanotechnology-powered CBD tablet it hopes can overcome the barriers that have kept cannabis compounds from becoming mainstream medicines. Australia legalised medicinal cannabis almost a decade ago, but the country has yet to approve a single CBD medicine for ordinary pain. Peter Comerford thinks he has found a way to change […]
Inside a Melbourne biotech’s attempt to decode the bizarre science of marsupial milk — and unlock a $2 billion market for premature-baby nutrition. For millions of years, marsupials have been solving a problem that human medicine is only now beginning to understand: how to tell a premature baby when to grow. Now two Melbourne scientists […]
After finding a molecule that could attack an intractable cancer protein, Ternarx has turned its sights on a harder, and potentially more profitable, target. For most of modern medicine, the basic job of a drug has been simple: find the protein causing the problem and block it. But New Scientist declared in May that we’ll […]
And the best seats in the house at the Men’s Rugby World Cup Australia 2027 are going for north of $20,000. Key Takeaways “This thing’s gonna be massive, and I just don’t think everyone’s ready, or aware, that it’s coming – and it’s coming in a year,” says David MacCallum, in charge of premium experiences […]
As the Cartier Women’s Initiative celebrates two decades of driving global change, the spotlight turns to three Australian trailblazers proving that local solutions can address complex global challenges. This story features in Issue 24 – out now. Tap here to secure your copy. When Rosie Dumbrell, a former Australian triathlete and physiotherapist, welcomed four children into the world in less […]
With market attention focused recently on mega-caps and new trillion-dollar AI listings SG Hiscock portfolio manager Rory Hunter is looking the other way. The micro-cap expert explains to Stewart Hawkins the joy (and dangers) of discovering mispriced stocks, how you navigate the risks among the unknown and the importance of giving your portfolio a fat […]
For two decades, the world’s biggest drugmakers tried to silence a single inflammatory receptor in the lungs and failed. Now, an Australian biotech company thinks it has found a solution. This story features in Issue 24 – out now. Tap here to secure your copy. You can’t breathe; you basically drown”, that’s how Siro Perez, chief […]
From former brothels and pubs to vineyards, apples and irrigation water, Ed Peter has made a fortune buying things other investors overlook. Now he’s preparing for the next economic reckoning. Ed Peter was looking at a financial model of his company’s apple orchards when his eyes fell on “pollination costs”. Something was amiss. He went […]
A dishwasher, a US export ban and a furious letter from RSA helped set two Brisbane programmers on a path to reshaping internet security. The first sign Tim Hudson had that his cryptographic software had arrived was when he bought a new dishwasher in 1998. The code written by his friend Eric Young and him […]
Pred Dragila was a retrenched banker and nightclub DJ when he became obsessed with fixing payments. Thirteen years later, his Fat Zebra processes $95 billion a year. This story features in Issue 24 – out now. Tap here to secure your copy. Pred Dragila was spinning discs at nightclubs. But the retrenched banker’s thoughts and conversation […]